Publications of C. T. Wotjak
All genres
Journal Article (195)
121.
Journal Article
90 (2), pp. 125 - 134 (2008)
Listening to neuropeptides by microdialysis: Echoes and new sounds? Pharmacology Biochemistry and Behavior 122.
Journal Article
11 (Suppl. 1), p. 117 - 117 (2008)
Conditional overexpression of corticotropin-releasing hormone in mice, an animal model for understanding the development of corticotropin-releasing hormone-mediated brain pathology. International Journal of Neuropsychopharmacology 123.
Journal Article
187, pp. 67 - 71 (2008)
Increased water temperature renders single-housed C57BL/6J mice susceptible to antidepressant treatment in the forced swim test. Behavioural Brain Research 124.
Journal Article
33 (1), pp. 54 - 67 (2008)
Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice. Psychoneuroendocrinology 125.
Journal Article
8 (3), pp. 196 - 208 (2008)
Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice. The Pharmacogenomics Journal 126.
Journal Article
186, pp. 191 - 196 (2008)
Long-lasting second stage of recognition memory consolidation in mice. Behavioural Brain Research 127.
Journal Article
41 (10), pp. 848 - 860 (2007)
A mouse model of posttraumatic stress disorder that distinguishes between conditioned and sensitised fear. Journal of Psychiatric Research 128.
Journal Article
5 (10), pp. 2354 - 2368 (2007)
Genetic dissection of behavioural and autonomic effects of Delta 9-Tetrahydrocannabinol in mice. PLoS Biology 129.
Journal Article
40 (5), p. 217 - 217 (2007)
Endocannabinoid signaling modulates HPA axis activity in the mouse - implications for depression disorders. Pharmacopsychiatry 130.
Journal Article
18 (Suppl. 1), pp. S72 - S73 (2007)
Nature or nurture? Revealing the effects of genetic background, sex, and maternal care on isolation-induced ultrasonic calling in mice pups by using a uterine-transfer procedure. Behavioural Pharmacology 131.
Journal Article
17 (Suppl. 1), p. S52 - S52 (2007)
The role of corticotropin-releasing-factor (CRF) for the development of PTSD-like symptoms in mice. European Neuropsychopharmacology 132.
Journal Article
90 (1), pp. 103 - 107 (2007)
Hyperarousal does not depend on trauma-related contextual memory in an animal model of Posttraumatic Stress Disorder. Physiology & Behavior 133.
Journal Article
27 (4), pp. 832 - 839 (2007)
Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice. The Journal of Neuroscience 134.
Journal Article
27 (1), p. 39 - 39 (2006)
Cannabinoid receptor 1 (CB1) signaling acts as a major regulatory mechanism of hypothalamus-pituitary-adrenal (HPA) axis mediated corticosterone secretion. Frontiers in Neuroendocrinology 135.
Journal Article
59 (8, Suppl. S), p. 163S - 163S (2006)
Genetic knockout and pharmacological blockade of cannabinoid receptor I affect stress coping behaviours in the mouse forced swim test. Biological Psychiatry 136.
Journal Article
372 (Suppl. 1), p. 60 - 60 (2006)
L-type voltage-gated calcium channels contribute to fear memory formation in the lateral amygdala. Naunyn-Schmiedebergs Archives of Pharmacology 137.
Journal Article
5 (Suppl. 2), pp. 5 - 24 (2006)
A hitchhiker's guide to behavioral analysis in laboratory rodents. Genes Brain and Behavior 138.
Journal Article
26 (21), pp. 5794 - 5799 (2006)
Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamergic synaptic transmission. The Journal of Neuroscience 139.
Journal Article
50, pp. 496 - 501 (2006)
Effects of Morris water maze testing on the neuroendocrine stress response and intrahypothalamic release of vasopressin and oxytocin in the rat. Hormones and Behavior 140.
Journal Article
26 (25), pp. 6677 - 6686 (2006)
Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes. The Journal of Neuroscience